FMR »

Xilio Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Xilio Therapeutics shares owned by FMR from 13F filings

Historical chart of FMR investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2026-03-31 $308k 37k 8.41

More positions owned by FMR

NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation Put Option (XOM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Netflix (NFLX)
Ge Vernova Put Option (GEV)
Ge Aerospace Com New (GE)
Visa Com Cl A (V)

View all positions for FMR

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Frazier Life Sciences Management
Sio Capital Management
Vanguard Capital Management
Caligan Partners
Merck & Co
Stonepine Capital Management
Morgan Stanley
Renaissance Technologies
AJU IB Investment
Geode Capital Management
FMR
Vanguard Fiduciary Trust
GSA Capital Partners
Velan Capital Investment Management

View all funds holding Xilio Therapeutics